Search research articles
Contact Us
Filters
Showing results (41-50 of 57) with videos related to
Page
of 6
Sort By:
British Journal of Cancer
|
April 22, 2015
Selective organ preservation with neo-adjuvant chemotherapy for the treatment of muscle invasive transitional cell carcinoma of the bladder
S Hafeez, A Horwich, O Omar, et al.
British Journal of Cancer
|
April 28, 2005
A modified Inflammatory Bowel Disease questionnaire and the Vaizey Incontinence questionnaire are simple ways to identify patients with significant gastrointestinal symptoms after pelvic radiotherapy
F A Olopade, A Norman, P Blake, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
June 16, 2019
Radiotherapy Quality Assurance for the CHHiP Trial: Conventional Versus Hypofractionated High-Dose Intensity-Modulated Radiotherapy in Prostate Cancer
O Naismith, H Mayles, M Bidmead, et al.
Journal of Medical Imaging and Radiation Oncology
|
July 24, 2009
Whole-body magnetic resonance imaging in the detection of skeletal metastases in patients with prostate cancer
R Venkitaraman, G J R Cook, D P Dearnaley, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
November 11, 2008
Does magnetic resonance imaging of the spine have a role in the staging of prostate cancer?
R Venkitaraman, G J R Cook, D P Dearnaley, et al.
Alimentary Pharmacology & Therapeutics
|
March 5, 2008
Clinical trial: normal diet vs. partial replacement with oral E028 formula for the prevention of gastrointestinal toxicity in cancer patients undergoing pelvic radiotherapy
C McGough, L Wedlake, C Baldwin, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
June 11, 2019
Forward- and Inverse-Planned Intensity-Modulated Radiotherapy in the CHHiP Trial: A Comparison of Dosimetry and Normal Tissue Toxicity
O F Naismith, C Griffin, I Syndikus, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
May 9, 2022
Assessing Bladder Radiotherapy Response With Quantitative Diffusion-Weighted Magnetic Resonance Imaging Analysis
S Hafeez, M Koh, K Jones, et al.
Prostate Cancer and Prostatic Diseases
|
September 3, 2008
Biopsy tissue microarray study of Ki-67 expression in untreated, localized prostate cancer managed by active surveillance
S Jhavar, J Bartlett, G Kovacs, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
April 28, 2015
Initial UK Experience of Stereotactic Body Radiotherapy for Extracranial Oligometastases: Can We Change the Therapeutic Paradigm?
K Aitken, A Tree, K Thomas, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 57) with videos related to
Sort By:
Page
of 6
British Journal of Cancer
|
April 22, 2015
Selective organ preservation with neo-adjuvant chemotherapy for the treatment of muscle invasive transitional cell carcinoma of the bladder
S Hafeez, A Horwich, O Omar, et al.
British Journal of Cancer
|
April 28, 2005
A modified Inflammatory Bowel Disease questionnaire and the Vaizey Incontinence questionnaire are simple ways to identify patients with significant gastrointestinal symptoms after pelvic radiotherapy
F A Olopade, A Norman, P Blake, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
June 16, 2019
Radiotherapy Quality Assurance for the CHHiP Trial: Conventional Versus Hypofractionated High-Dose Intensity-Modulated Radiotherapy in Prostate Cancer
O Naismith, H Mayles, M Bidmead, et al.
Journal of Medical Imaging and Radiation Oncology
|
July 24, 2009
Whole-body magnetic resonance imaging in the detection of skeletal metastases in patients with prostate cancer
R Venkitaraman, G J R Cook, D P Dearnaley, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
November 11, 2008
Does magnetic resonance imaging of the spine have a role in the staging of prostate cancer?
R Venkitaraman, G J R Cook, D P Dearnaley, et al.
Alimentary Pharmacology & Therapeutics
|
March 5, 2008
Clinical trial: normal diet vs. partial replacement with oral E028 formula for the prevention of gastrointestinal toxicity in cancer patients undergoing pelvic radiotherapy
C McGough, L Wedlake, C Baldwin, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
June 11, 2019
Forward- and Inverse-Planned Intensity-Modulated Radiotherapy in the CHHiP Trial: A Comparison of Dosimetry and Normal Tissue Toxicity
O F Naismith, C Griffin, I Syndikus, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
May 9, 2022
Assessing Bladder Radiotherapy Response With Quantitative Diffusion-Weighted Magnetic Resonance Imaging Analysis
S Hafeez, M Koh, K Jones, et al.
Prostate Cancer and Prostatic Diseases
|
September 3, 2008
Biopsy tissue microarray study of Ki-67 expression in untreated, localized prostate cancer managed by active surveillance
S Jhavar, J Bartlett, G Kovacs, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
April 28, 2015
Initial UK Experience of Stereotactic Body Radiotherapy for Extracranial Oligometastases: Can We Change the Therapeutic Paradigm?
K Aitken, A Tree, K Thomas, et al.
Page
of 6